SENSICARDIAC vs KardiaAI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC

by Diacoustic Medical Devices (Pty) Ltd.

KardiaAI

by AliveCor

AI Verdict

SENSICARDIAC focuses on AI-powered heart murmur detection using electronic stethoscope data, classifying murmurs as pathological or physiological. In contrast, KardiaAI specializes in analyzing ambulatory ECG rhythms to detect various electrical cardiac conditions such as AFib, bradycardia, and tachycardia. While both leverage AI for cardiac diagnostics, they address distinct physiological signals and conditions, making them suitable for different diagnostic pathways.

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your primary need is an AI-powered solution for real-time heart murmur detection and classification using electronic stethoscopes. This tool is ideal for physicians in primary care, internal medicine, or pediatrics who require assistance in screening for pathological murmurs, reducing unnecessary referrals, and conducting guided auscultation remotely.

View SENSICARDIAC →

Choose KardiaAI if…

Choose KardiaAI if your focus is on leveraging an FDA-cleared AI software library for the analysis of ambulatory ECG rhythms to detect specific cardiac arrhythmias. This tool is best suited for integrating into existing ECG devices or platforms to accurately identify conditions such as atrial fibrillation, bradycardia, and tachycardia, providing medical-grade rhythm data interpretation.

View KardiaAI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC	KardiaAI
Pricing	Unknown	Subscription-based for advanced features and services.
Deployment	SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser.	Mobile app, cloud-based.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC

SENSICARDIAC offers a 'guided auscultation process' and 'real-time analysis' with 'downloadable PDFs, visualization,' suggesting a direct, interactive user experience for clinicians performing auscultation. User testing data for SensiCardiac Mobi, a related product, indicated high usability with an average score of more than 4 out of 5 by intended users. In contrast, KardiaAI is primarily an 'AI software library' and 'API library,' meaning its direct usability depends heavily on the application it's integrated into, rather than providing a standalone user interface.

Clinical Value

KardiaAI

Both tools are FDA-cleared and provide significant clinical value. SENSICARDIAC aids in differentiating pathological from physiological heart murmurs, which can reduce unnecessary specialist referrals. KardiaAI offers a broader range of FDA-cleared ECG rhythm detections, including atrial fibrillation, bradycardia, tachycardia, and various ectopies, which are critical for managing a wider spectrum of cardiac conditions and are supported by numerous clinical validation studies. The breadth of conditions detected by KardiaAI provides a more comprehensive clinical utility for rhythm analysis.

Pricing & Value

KardiaAI

KardiaAI provides clear, publicly available subscription pricing for its integrated services, allowing potential users to easily understand the cost and assess its value (KardiaCare Monthly: $13.99/month; KardiaCare Annual: $99.99/year; KardiaCare Plus: $199/year). SENSICARDIAC's pricing is not publicly available, requiring direct contact for details, which makes it challenging to evaluate its cost-effectiveness and overall value proposition without further engagement.

Enterprise Readiness

KardiaAI

Both tools demonstrate enterprise readiness through HIPAA compliance and BAA availability. SENSICARDIAC offers cloud and desktop deployment, and can be white-labeled for telehealth integrators. However, KardiaAI is explicitly designed as an 'API library integrated into mobile apps and web platforms' and offers an SDK for developers, providing flexible integration into existing enterprise systems and workflows, which is crucial for large-scale adoption and customization.

Innovation

SENSICARDIAC

SENSICARDIAC demonstrates innovation through its integration with electronic stethoscopes for live, AI-powered heart murmur detection and classification, offering a novel approach to remote auscultation with 'LIVE diagnostic quality stethoscope streaming'. It also features a 'guided auscultation process' and a '3D interactive patient model' for stethoscope placement. While KardiaAI's FDA-cleared AI library for ECG analysis is foundational, SENSICARDIAC's focus on real-time, AI-driven auscultation represents a distinct advancement in a traditionally manual diagnostic area.

Support & Docs

KardiaAI

AliveCor, the company behind KardiaAI, offers extensive support resources, including user manuals in multiple languages, FAQs, and dedicated developer documentation for its API and SDK. This comprehensive documentation and developer-focused support are critical for successful integration and implementation of an API library. While SENSICARDIAC provides a user manual and contact information, the breadth of publicly available developer-centric documentation and support appears more robust for KardiaAI.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC	KardiaAI
Name	SENSICARDIAC	KardiaAI
Company	DIACOUSTIC MEDICAL (PTY)	AliveCor
Primary Function	AI-powered heart murmur detection service	AI software library for analyzing ambulatory ECG rhythms
Key Detections/Analysis	Pathological/physiological heart murmur classification, S1/S2 indicators	Atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, Sinus Rhythm with Supraventricular Ectopy (SVE)
Integration	Electronic stethoscopes (e.g., 3M Littmannu00ae 3200)	API library for integration into other ECG devices and software

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC and KardiaAI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do SENSICARDIAC and KardiaAI integrate into a physician's existing cardiac assessment workflow, and for which specific clinical scenarios are they most beneficial?

SENSICARDIAC integrates with electronic stethoscopes for real-time, guided auscultation and AI-powered heart murmur detection, aiding in diagnosis and reducing unnecessary referrals, particularly in Cardiology, Internal Medicine, and Pediatrics. KardiaAI provides an AI software library for analyzing ambulatory ECG rhythms to detect conditions like AFib, bradycardia, and tachycardia, transforming cardiology with medical-grade AI solutions for specialties including Cardiology, Emergency Medicine, and Internal Medicine.

What is the extent of EHR integration for each tool, and how are the generated reports or analysis results incorporated into patient records?

SENSICARDIAC generates detailed cardiac reports as downloadable PDFs with visualization and S1/S2 indicators, which can be incorporated into patient records. KardiaAI is an API library designed for integration into mobile apps and web platforms, suggesting that its analysis results would be accessible through those integrated systems.

What specific accuracy and sensitivity metrics are available for the AI algorithms in detecting heart murmurs (SENSICARDIAC) and various arrhythmias (KardiaAI)?

SENSICARDIAC performs analysis against a large validated database of pathological heart murmurs to classify them as dangerous pathological (Class I) or innocent physiological (Class III). KardiaAI offers medical-grade accuracy for heart rhythm data, detecting conditions such as atrial fibrillation, bradycardia, tachycardia, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, and Sinus Rhythm with Supraventricular Ectopy (SVE).

What is the typical learning curve for physicians and their staff to effectively use each tool, and what is the estimated time-to-value for seeing clinical benefits?

SENSICARDIAC features a guided auscultation process, suggesting a streamlined user experience to aid physicians in diagnosis and potentially reduce unnecessary referrals. KardiaAI, as an API library integrated into other platforms, would have its learning curve dependent on the host application, but aims to transform cardiology with its medical-grade AI solutions.

Do these tools offer robust audit-trail features for tracking AI analysis and physician review, and what considerations are there for multi-site or large-scale institutional rollouts?

SENSICARDIAC provides detailed cardiac reports as downloadable PDFs, which can serve as a record of the AI analysis and physician review. For multi-site rollouts, its cloud-based nature suggests scalability, while KardiaAI's API library allows for integration into various platforms, which could facilitate centralized tracking and management across multiple sites depending on the implementation.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring SENSICARDIAC or KardiaAI

Backers

Who funded each tool's parent company.